Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study

Kennelly SP, Abdullah L, Paris D, Parish J, Mathura V, Mullan M, Crawford F, Lawlor BA, Kenny RA.

Int J Geriatr Psychiatry. 2011 Oct;26(10):1038-45. doi: 10.1002/gps.2638. Epub 2010 Oct 29.

Assessment of dementia in ethnic minority patients in Europe: a European Alzheimer's Disease Consortium survey

Nielsen TR, Vogel A, Riepe MW, de Mendonça A, Rodriguez G, Nobili F, Gade A, Waldemar G.

Int Psychogeriatr. 2011 Feb;23(1):86-95. doi: 10.1017/S1041610210000955. Epub 2010 Jul 6.

Effects of cognitive function and depressive mood on the quality of life in Chinese Alzheimer's disease patients in Hong Kong

Chan IW, Chu LW, Lee PW, Li SW, Yu KK.

Geriatr Gerontol Int. 2011 Jan;11(1):69-76. doi: 10.1111/j.1447-0594.2010.00643.x. Epub 2010 Aug 25.

Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis

Crean S, Ward A, Mercaldi CJ, Collins JM, Cook MN, Baker NL, Arrighi HM.

Dement Geriatr Cogn Disord. 2011;31(1):20-30. doi: 10.1159/000321984. Epub 2010 Dec 1.

Association of DAPK1 genetic variations with Alzheimer's disease in Han Chinese

Wu ZC, Zhang W, Yu JT, Zhang Q, Tian Y, Lu RC, Yu NN, Chi ZF, Tan L.

Brain Res. 2011 Feb 16;1374:129-33. doi: 10.1016/j.brainres.2010.12.036. Epub 2010 Dec 16.

Conjugated polymers for enhanced bioimaging

Klingstedt T, Nilsson KP.

Biochim Biophys Acta. 2011 Mar;1810(3):286-96. doi: 10.1016/j.bbagen.2010.05.003. Epub 2010 May 13.

The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease

Mitchell RA, Herrmann N, Lanctôt KL.

CNS Neurosci Ther. 2011 Oct;17(5):411-27. doi: 10.1111/j.1755-5949.2010.00161.x. Epub 2010 Jun 16.

Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education?

Aprahamian I, Martinelli JE, Cecato J, Izbicki R, Yassuda MS.

Int Psychogeriatr. 2011 Feb;23(1):96-101. doi: 10.1017/S104161021000116X. Epub 2010 Aug 3.

Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality

Ballard C, Creese B, Corbett A, Aarsland D.

Expert Opin Drug Saf. 2011 Jan;10(1):35-43. doi: 10.1517/14740338.2010.506711. Epub 2010 Aug 5.

Third degree heart block following intramuscular ziprasidone

Tambyraja R, Strawn JR.

Schizophr Res. 2011 Feb;125(2-3):302-3. doi: 10.1016/j.schres.2010.07.015. Epub 2010 Aug 7.

Donepezil treatment in Alzheimer's disease patients with and without cerebrovascular lesions: a preliminary report

Na HR, Kim S, Choi SH, Yang DW, Bae HJ, Kim JE, Park MY, Shim YS, Kim BK, Kwon JC, Yoo BG, Kim BC, Lee JS.

Geriatr Gerontol Int. 2011 Jan;11(1):90-7. doi: 10.1111/j.1447-0594.2010.00649.x. Epub 2010 Sep 3.

Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes

Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S.

Arch Neurol. 2011 Jan;68(1):51-7. doi: 10.1001/archneurol.2010.225. Epub 2010 Sep 13.

A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease

Geldmacher DS, Fritsch T, McClendon MJ, Landreth G.

Arch Neurol. 2011 Jan;68(1):45-50. doi: 10.1001/archneurol.2010.229. Epub 2010 Sep 13.

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease

Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, Wakuda T, Sugihara G, Takebayashi K, Suda S, Iwata Y, Ueki T, Tsuchiya KJ, Suzuki K, Nakamura K, Ouchi Y.

Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):343-51. doi: 10.1007/s00259-010-1612-0. Epub 2010 Sep 16.

Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease

Brioni JD, Esbenshade TA, Garrison TR, Bitner SR, Cowart MD.

J Pharmacol Exp Ther. 2011 Jan;336(1):38-46. doi: 10.1124/jpet.110.166876. Epub 2010 Sep 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias